Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Soumyajit Majumdar"'
Autor:
Poorva H. Joshi, Ahmed Adel Ali Youssef, Mihir Ghonge, Corinne Varner, Siddharth Tripathi, Narendar Dudhipala, Soumyajit Majumdar
Publikováno v:
Antibiotics, Vol 12, Iss 8, p 1318 (2023)
Bacterial conjunctivitis (BC) entails inflammation of the ocular mucous membrane. Early effective treatment of BC can prevent the spread of the infection to the intraocular tissues, which could lead to bacterial endophthalmitis or serious visual disa
Externí odkaz:
https://doaj.org/article/58c12e4f80e341b795b7e1ad8063a34d
Autor:
Samir Senapati, Ahmed Adel Ali Youssef, Corinne Sweeney, Chuntian Cai, Narendar Dudhipala, Soumyajit Majumdar
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2585 (2022)
Cannabidiol (CBD) is the major non-psychoactive and most widely studied of the cannabinoid constituents and has great therapeutic potential in a variety of diseases. However, contradictory reports in the literature with respect to CBD’s effect on i
Externí odkaz:
https://doaj.org/article/0b50b1ed51dc4c148280f7e06cc4c25a
Autor:
Ahmed Adel Ali Youssef, Ruchi Thakkar, Samir Senapati, Poorva H. Joshi, Narendar Dudhipala, Soumyajit Majumdar
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1246 (2022)
Ocular bacterial infections can lead to serious visual disability without proper treatment. Moxifloxacin (MOX) has been approved by the US Food and Drug Administration as a monotherapy for ocular bacterial infections and is available commercially as
Externí odkaz:
https://doaj.org/article/a706e4bbbe9f401197795367aa874e42
Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel
Autor:
Sushrut Marathe, Gauri Shadambikar, Tabish Mehraj, Suresh P. Sulochana, Narendar Dudhipala, Soumyajit Majumdar
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1034 (2022)
The management of retinoblastoma (RB) involves the use of invasive treatment regimens. Paclitaxel (PTX), an effective antineoplastic compound used in the treatment of a wide range of malignant tumors, poses treatment challenges due to systemic toxici
Externí odkaz:
https://doaj.org/article/0fe4bb683fa045548023c1b1aa5a41d3
Autor:
Goutham R. Adelli, Sai Prachetan Balguri, Prakash Bhagav, Vijayasankar Raman, Soumyajit Majumdar
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 370-379 (2017)
Purpose: The goal of the present study is to develop polymeric matrix films loaded with a combination of free diclofenac sodium (DFSfree) and DFS:Ion exchange resin complexes (DFS:IR) for immediate and sustained release profiles, respectively. Method
Externí odkaz:
https://doaj.org/article/2ce67b34cdcc4cb5a34108045059d3fd
Publikováno v:
Pharmaceuticals, Vol 14, Iss 3, p 210 (2021)
Bacterial keratitis (BK) is a critical ocular infection that can lead to serious visual disability. Ciprofloxacin (CIP), moxifloxacin (MOX), and levofloxacin (LFX) have been accepted as monotherapies by the US Food and Drug Administration for BK trea
Externí odkaz:
https://doaj.org/article/100cff3582ca4591a58152d06aaf9279
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 572 (2020)
Bacterial endophthalmitis (BE) is a potentially sight-threatening inflammatory reaction of the intraocular fluids or tissues caused by bacteria. Ciprofloxacin (CIP) eye drops are prescribed as first-line therapy in BE. However, frequent administratio
Externí odkaz:
https://doaj.org/article/f65f48526364462c91f690b17a38e8c2
Autor:
Akshaya Tatke, Narendar Dudhipala, Karthik Yadav Janga, Bhavik Soneta, Bharathi Avula, Soumyajit Majumdar
Publikováno v:
Pharmaceutics, Vol 11, Iss 4, p 158 (2019)
Delivering an effective drug load to the posterior section of the ocular tissues, while using a non-invasive technique, has always been a challenge. In this regard, the goal of the present study was to develop sustained release triamcinolone acetonid
Externí odkaz:
https://doaj.org/article/2a97b6b6cbf0428d9a729ceb11690214
Autor:
Akshaya Tatke, Narendar Dudhipala, Karthik Yadav Janga, Sai Prachetan Balguri, Bharathi Avula, Monica M. Jablonski, Soumyajit Majumdar
Publikováno v:
Nanomaterials, Vol 9, Iss 1, p 33 (2018)
Triamcinolone acetonide (TA), an intermediate acting corticosteroid, is used in the treatment of posterior ocular diseases, such as inflammation, posterior uveitis, and diabetic macular edema. The objective of this investigation was to prepare TA-loa
Externí odkaz:
https://doaj.org/article/c0ed33f523874c88bdc834714720de2f
Autor:
Indrajeet Karnik, Ahmed Adel Ali Youssef, Poorva Joshi, Siva Ram Munnangi, Sagar Narala, Corinne Varner, Sateesh Kumar Vemula, Soumyajit Majumdar, Michael Repka
Publikováno v:
Journal of Drug Delivery Science and Technology. 84:104558